• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Development of universal influenza vaccines based on influenza virus M and NP genes

tetano

Editor, Senior Moderator
Infection. 2013 Nov 1. [Epub ahead of print]
Development of universal influenza vaccines based on influenza virus M and NP genes.
Zheng M, Luo J, Chen Z.
Source

Shanghai Institute of Biological Products, Shanghai, 200052, China.
Abstract
PURPOSE:

Vaccination is the safest and most effective measure against influenza virus infections. However, traditional influenza vaccines cannot respond effectively to an unforeseen epidemic or pandemic caused by a virus with antigenic drifts or antigenic shifts. Therefore, developing a universal influenza vaccine (UIV) that induces broad-spectrum and long-term immunity has become a major trend in influenza vaccine research and development.
METHODS:

This article reviews the development of UIVs based on these conserved influenza virus proteins.
RESULTS AND CONCLUSION:

The matrix protein (M1, M2) and nucleoprotein (NP) of influenza viruses have highly conserved sequences, and they become the major target antigens of current UIV studies.

PMID:
24178189
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24178189
 
Back
Top Bottom